Daratumumab
Records for this ingredient, by country (identity only).
ATC L01FC01 · 11 markets · 44 records
AU 10 records · 6 shown of 6
Only this ingredient
- 100 mg/5 mLinjectionDARZALEX
- 1,800 mg/15 mLinjectionDarzalex SC
- 1,800 mg per mL / per unit basis not statedinjectionDARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial
- 400 mg/20 mLinjectionDARZALEX
- 400 mg per mL / per unit basis not statedinjectionDARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial
- 100 mg per mL / per unit basis not statedinjectionDARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 7 records · 2 shown of 2
US 3 records · 2 shown of 2
Only this ingredient
- 100 mg/5 mLinjectionDARZALEXDarzalex IV
Combination products containing this ingredient
- 1,800 mg/15 mLinjection CombinationDaratumumab 1,800 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 unit/15 mLDarzalex Faspro
GB 3 records · 3 shown of 3
Only this ingredient
- 100 mg/5 mLinjectionDarzalex 100mg/5ml concentrate for solution for infusion vials
- 1,800 mg/15 mLinjectionDarzalex 1800mg/15ml solution for injection vials
- 400 mg/20 mLinjectionDarzalex 100mg/5ml concentrate for solution for infusion vials
CA 3 records · 2 shown of 2
Only this ingredient
- 120 mg/1 mLliquidDarzalex SC
- 20 mg/1 mLliquidDARZALEX
SG 3 records · 3 shown of 3
Only this ingredient
- 100 mg/5 mLinjectionDARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML
- 1,800 mg/15 mLinjectionDARZALEX SC SOLUTION FOR INJECTION 1800MG/15ML
- 400 mg/20 mLinjectionDARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML
HK 3 records · 0 shown of 0
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 3 records · 3 shown of 3
Only this ingredient
- 100 mg/5 mLinjectionダラザレックス点滴静注400mg
- 400 mg/20 mLinjectionダラザレックス点滴静注400mg
Combination products containing this ingredient
- 15 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 15 mL + Daratumumab 15 mLダラキューロ配合皮下注
TW 2 records · 1 shown of 1
Only this ingredient
- 1,800 mg per mL / per unit basis not statedinjectionDarzalex 1800mg solution for subcutaneous兆科皮下注射劑1800毫克
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 shown of 2
Only this ingredient
- 1,800 mg/15 mLinjectionDARZALEX 1800 mg, solution injectable
- 20 mg/1 mLinjectionDARZALEX 20 mg/mL, solution à diluer pour perfusion
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg/5 mL injection | DARZALEX Darzalex IV | Darzalex 100mg/5ml concentrate for solution for infusion vials | DARZALEX | DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML | ダラザレックス点滴静注400mg | ||||||
| 1,800 mg/15 mLRecorded as: 1.8 g/15 mL injection | Darzalex 1800mg/15ml solution for injection vials | Darzalex SC | DARZALEX SC SOLUTION FOR INJECTION 1800MG/15ML | DARZALEX 1800 mg, solution injectable | |||||||
| 1,800 mg per mL / per unit basis not stated cannot compare injection | DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial | DARZALEX | Darzalex 1800mg solution for subcutaneous 兆科皮下注射劑1800毫克 | ||||||||
| 400 mg/20 mL injection | Darzalex 100mg/5ml concentrate for solution for infusion vials | DARZALEX | DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML | ダラザレックス点滴静注400mg | |||||||
| 20 mg/1 mL injection | DARZALEX | DARZALEX 20 mg/mL, solution à diluer pour perfusion | |||||||||
| 120 mg/1 mL liquid | Darzalex SC | ||||||||||
| 20 mg/1 mL liquid | DARZALEX | ||||||||||
| 400 mg per mL / per unit basis not stated cannot compare injection | DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial | ||||||||||
| 100 mg per mL / per unit basis not stated cannot compare injection | DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial | ||||||||||
| 1,800 mg/15 mL Combination Daratumumab 1,800 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 unit/15 mL injection | Darzalex Faspro | ||||||||||
| 15 mL per mL / per unit basis not stated cannot compare Combination Berahyaluronidase Alfa 15 mL + Daratumumab 15 mL injection | ダラキューロ配合皮下注 | ||||||||||
unknown | DARZALEX Darzalex SC | Darzalex 1800mg solution for subcutaneous injection DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/5ML (SWITZERLAND) DARZALEX CONCENTRATE FOR SOLUTION FOR INFUSION 400MG/20ML | DARZALEX | ||||||||
injection | Darzalex Concentrate for solution for infusion 20mg/ml 兆科注射劑20毫克/毫升 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · ES · JP · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · ES · JP · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · ES · JP · FR 有记录（未在本表显示）。 另有 4 個規格/劑型僅在 CA · ES · JP · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.